Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Mario Mandala.
Connection Strength
0.289
-
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer. 2021 02; 9(2).
Score: 0.232
-
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. J Immunother Cancer. 2021 01; 9(1).
Score: 0.058